Cargando…

Willingness to pay for a cure of low-risk melanoma patients in Germany

Malignant melanoma is potentially life-threatening but in most cases curable if detected early. Willingness to pay (WTP) is a preference-based construct that reflects burden of disease by assessment of the monetary value for a hypothetical cure from disease. Since WTP (directly as total amount of mo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Augustin, Matthias, Blome, Christine, Forschner, Andrea, Gutzmer, Ralf, Hauschild, Axel, Heinzerling, Lucie, Livingstone, Elisabeth, Loquai, Carmen, Schadendorf, Dirk, Utikal, Jochen, Wagner, Tobias, Wilden, Sophia, Kähler, Katharina C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5967822/ https://www.ncbi.nlm.nih.gov/pubmed/29795621 http://dx.doi.org/10.1371/journal.pone.0197780

Ejemplares similares

The outweigh of toxicity versus risk of recurrence for adjuvant interferon therapy: a survey in German melanoma patients and their treating physicians
por: Kähler, Katharina C., et al.
Publicado: (2018)

Preferences of German melanoma patients for interferon (IFN) α-2b toxicities (the DeCOG “GERMELATOX survey”) versus melanoma recurrence to quantify patients’ relative values for adjuvant therapy
por: Kaehler, Katharina C., et al.
Publicado: (2016)

Therapy Preferences in Melanoma Treatment - Willingness to Pay and Preference of Quality versus Length of Life of Patients, Physicians and Healthy Controls
por: Krammer, Ramona, et al.
Publicado: (2014)

Early Exanthema Upon Vemurafenib Plus Cobimetinib Is Associated With a Favorable Treatment Outcome in Metastatic Melanoma: A Retrospective Multicenter DeCOG Study
por: Kähler, Katharina C., et al.
Publicado: (2021)

10 Years of AMNOG: What is the Willingness-to-Pay for Pharmaceuticals in Germany?
por: Büssgen, Melanie, et al.
Publicado: (2023)

Therapy preferences in melanoma treatment—Willingness to pay and preference of quality versus length of life of patients, physicians, healthy individuals and physicians with oncological disease
por: Weiss, Julia, et al.
Publicado: (2020)

Real-World Therapy with Pembrolizumab: Outcomes and Surrogate Endpoints for Predicting Survival in Advanced Melanoma Patients in Germany
por: Mohr, Peter, et al.
Publicado: (2022)

Clinical outcome of concomitant vs interrupted BRAF inhibitor therapy during radiotherapy in melanoma patients
por: Hecht, Markus, et al.
Publicado: (2018)

Feasibility of assessing utilities with a single-item standard gamble questionnaire in patients with melanoma
por: Blome, Christine, et al.
Publicado: (2021)

Willingness to pay and moral stance: The case of farm animal welfare in Germany
por: Frey, Ulrich J., et al.
Publicado: (2018)

Correction: Willingness to pay and moral stance: The case of farm animal welfare in Germany
Publicado: (2018)

Effectiveness, Safety and Utilization of Vismodegib for Locally Advanced Basal Cell Carcinoma Under Real-world Conditions: Non-interventional Cohort Study JONAS
por: KAATZ, Martin, et al.
Publicado: (2022)

Study of Patients’ Willingness to Pay for a Cure of Chronic Obstructive Pulmonary Disease in Taiwan
por: Chen, Yi-Ting, et al.
Publicado: (2016)

Data of a willingness to pay survey for national climate change mitigation policies in Germany
por: Uehleke, Reinhard
Publicado: (2016)

No Cure, No Pay
Publicado: (1886)

Willingness to Pay for a Dating App: Psychological Correlates
por: Rochat, Lucien, et al.
Publicado: (2023)

Can Deliberative Participatory Fora Cure Representation Gaps in France and Germany?
por: Blome, Agnes, et al.
Publicado: (2023)

Willingness to pay in medical education
por: Walsh, Kieran
Publicado: (2014)

Willingness-to-pay for sustainable beer
por: Carley, Sanya, et al.
Publicado: (2018)

Assessment of various efficacy outcomes using ERIVANCE-like criteria in patients with locally advanced basal cell carcinoma receiving sonidegib: results from a preplanned sensitivity analysis
por: Gutzmer, Ralf, et al.
Publicado: (2021)

Tolerability of BRAF and MEK Inhibitors for Metastasized Melanoma after Intra-Class Switch: A Multicenter, Retrospective Study
por: Salzmann, Martin, et al.
Publicado: (2023)

Preferences of German and Swiss melanoma patients for toxicities versus melanoma recurrence during adjuvant treatment (GERMELATOX-A-trial)
por: Kähler, Katharina C., et al.
Publicado: (2023)

Impact of a preceding radiotherapy on the outcome of immune checkpoint inhibition in metastatic melanoma: a multicenter retrospective cohort study of the DeCOG
por: Knispel, Sarah, et al.
Publicado: (2020)

Chemosensitivity-directed therapy compared to dacarbazine in chemo-naive advanced metastatic melanoma: a multicenter randomized phase-3 DeCOG trial
por: Ugurel, Selma, et al.
Publicado: (2017)

Factors influencing willingness to pay for healthcare
por: Noor Aizuddin, Azimatun, et al.
Publicado: (2012)

Frontal Brain Asymmetry and Willingness to Pay
por: Ramsøy, Thomas Z., et al.
Publicado: (2018)

Public Perceptions and Willingness-to-Pay for Nanopesticides
por: Liu, Peiyuan, et al.
Publicado: (2022)

Medikamentöse Therapie des inoperablen Melanoms
por: Lodde, Georg, et al.
Publicado: (2023)

Clinical and molecular characteristics associated with response to therapeutic PD-1/PD-L1 inhibition in advanced Merkel cell carcinoma
por: Spassova, Ivelina, et al.
Publicado: (2022)

Factors Influencing the Adjuvant Therapy Decision: Results of a Real-World Multicenter Data Analysis of 904 Melanoma Patients
por: Lodde, Georg, et al.
Publicado: (2021)

Analysis of Nutritional Characteristics and Willingness to Pay of Consumers for Dry-Cured Sausages (Salchichón) Made with Textured Seed Oils
por: Tarjuelo, Laura, et al.
Publicado: (2023)

A “No-Cure, No-Pay” Decision
Publicado: (1884)

Results of the Willingness To Pay Study for FCC in Switzerland.
por: Giffoni, Francesco
Publicado: (2020)

Brand equity and willingness to pay for condoms in zimbabwe
por: Evans, W Douglas, et al.
Publicado: (2011)

Willingness To Pay for Social Health Insurance in Iran
por: Nosratnejad, Shirin, et al.
Publicado: (2014)

Willingness to pay for colorectal cancer screening in Guangzhou
por: Zhou, Qin, et al.
Publicado: (2018)

Data for the analysis of willingness to pay for Italian beaches
por: Rodella, Ilaria, et al.
Publicado: (2019)

Understanding the global measurement of willingness to pay in health
por: McDougall, Jean A., et al.
Publicado: (2020)

Willingness to Pay for a COVID-19 Vaccine
por: Cerda, Arcadio A., et al.
Publicado: (2021)

Parents’ willingness to pay for children’s spectacles in Cambodia
por: Burnett, Anthea, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_d14valcst9k734i5euaie2q7al